These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 7119025)

  • 1. Fibronectin inhibits morphological changes in cultures of vascular smooth muscle cells.
    Brennan MJ; Millis AJ; Fritz KE
    J Cell Physiol; 1982 Aug; 112(2):284-90. PubMed ID: 7119025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural alterations in fibronectin correlated with morphological changes in smooth muscle cells.
    Brennan MJ; Millis AJ; Mann D; Fritz KE
    Dev Biol; 1983 Jun; 97(2):391-7. PubMed ID: 6852370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro expression of a 38,000 dalton heparin-binding glycoprotein by morphologically differentiated smooth muscle cells.
    Millis AJ; Hoyle M; Kent L
    J Cell Physiol; 1986 Jun; 127(3):366-72. PubMed ID: 3086326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clusterin regulates vascular smooth muscle cell nodule formation and migration.
    Millis AJ; Luciani M; McCue HM; Rosenberg ME; Moulson CL
    J Cell Physiol; 2001 Feb; 186(2):210-9. PubMed ID: 11169458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clusterin (Apo J) regulates vascular smooth muscle cell differentiation in vitro.
    Moulson CL; Millis AJ
    J Cell Physiol; 1999 Sep; 180(3):355-64. PubMed ID: 10430175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cultivated human arterial smooth muscle displays heterogeneous pattern of growth and phenotypic variation.
    Björkerud S
    Lab Invest; 1985 Sep; 53(3):303-10. PubMed ID: 3897707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial heparan sulfate is necessary but not sufficient for control of vascular smooth muscle cell growth.
    Ettenson DS; Koo EW; Januzzi JL; Edelman ER
    J Cell Physiol; 2000 Jul; 184(1):93-100. PubMed ID: 10825238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and characterization of a Mr = 38,000 protein from differentiating smooth muscle cells.
    Millis AJ; Hoyle M; Reich E; Mann DM
    J Biol Chem; 1985 Mar; 260(6):3754-61. PubMed ID: 3972846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coculture of endothelial cells and smooth muscle cells in bilayer and conditioned media models.
    Fillinger MF; Sampson LN; Cronenwett JL; Powell RJ; Wagner RJ
    J Surg Res; 1997 Feb; 67(2):169-78. PubMed ID: 9073564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incorporation of cellular and plasma fibronectins into smooth muscle cell extracellular matrix in vitro.
    Millis AJ; Hoyle M; Mann DM; Brennan MJ
    Proc Natl Acad Sci U S A; 1985 May; 82(9):2746-50. PubMed ID: 3887410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth, biochemistry, and morphology of isolated rabbit aortic smooth muscle cells maintained in the presence or absence of serum.
    Yau-Young AO; Shio H; Fowler S
    J Cell Physiol; 1981 Sep; 108(3):461-73. PubMed ID: 7287830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Density-dependent endothelial cell production of an inhibitor of smooth muscle cell growth.
    Dodge AB; Lu X; D'Amore PA
    J Cell Biochem; 1993 Sep; 53(1):21-31. PubMed ID: 8227180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atheromatous plaque macrophages produce plasminogen activator inhibitor type-1 and stimulate its production by endothelial cells and vascular smooth muscle cells.
    Tipping PG; Davenport P; Gallicchio M; Filonzi EL; Apostolopoulos J; Wojta J
    Am J Pathol; 1993 Sep; 143(3):875-85. PubMed ID: 8362983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The production and localization of laminin in cultured vascular and corneal endothelial cells.
    Gospodarowicz D; Greenburg G; Foidart JM; Savion N
    J Cell Physiol; 1981 May; 107(2):171-83. PubMed ID: 7251679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered fibronectin-dependent cell adhesion by PDGF accompanies phenotypic modulation of vascular smooth muscle cells.
    Fujio Y; Yamada F; Takahashi K; Shibata N
    Biochem Biophys Res Commun; 1993 Oct; 196(2):997-1002. PubMed ID: 7694583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in elastin-binding proteins during the phenotypic transition of rabbit arterial smooth muscle cells in primary culture.
    Yamamoto K; Aoyagi M; Yamamoto M
    Exp Cell Res; 1995 May; 218(1):339-45. PubMed ID: 7737370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human-derived vascular smooth muscle cells produce angiotensin II by changing to the synthetic phenotype.
    Hu WY; Fukuda N; Ikeda Y; Suzuki R; Tahira Y; Takagi H; Matsumoto K; Kanmatsuse K; Mugishima H
    J Cell Physiol; 2003 Aug; 196(2):284-92. PubMed ID: 12811821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional interplay between interleukin-1 receptor and elastin binding protein regulates fibronectin production in coronary artery smooth muscle cells.
    Hinek A; Molossi S; Rabinovitch M
    Exp Cell Res; 1996 May; 225(1):122-31. PubMed ID: 8635505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of smooth muscle cell proliferation and phenotype by integrin signaling through focal adhesion kinase.
    Morla AO; Mogford JE
    Biochem Biophys Res Commun; 2000 May; 272(1):298-302. PubMed ID: 10872843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions between cultured bovine arterial endothelial and smooth muscle cells; further studies on the effects of injury and modification of the consequences of injury.
    Xu CB; Stavenow L; Pessah-Rasmussen H
    Artery; 1993; 20(3):163-79. PubMed ID: 8240033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.